Skip to content

CHICAGO–(BUSINESS WIRE)–Feb. 17, 2005–Allscripts Healthcare
Solutions, Inc. (NASDAQ:MDRX), the leading provider of clinical
software, connectivity and information solutions that physicians use
to improve healthcare, announced its results for the three months and
year ended December 31, 2004.

Total revenue for the three months ended December 31, 2004, was
$26.3 million, compared to $23.7 million for the three months ended
December 31, 2003. Revenue from clinical software and information
services for the three months ended December 31, 2004, was $17.0
million, increasing 44% over the comparable period last year.

Net income for the three months ended December 31, 2004, of $1.4
million or $0.03 per diluted share, compares to a net income of $0.1
million or $0.00 per share, for the same period last year.

As of December 31, 2004, the Company had cash and marketable
securities of $128.2 million.

“2004 was an exceptional year for Allscripts,” commented Glen
Tullman, Chief Executive Officer of Allscripts. “Providing physicians
with the information they need and connectivity to key healthcare
stakeholders offers an opportunity to transform the way healthcare is
delivered. The demand for our products has never been stronger.”

Total revenue for the twelve months ended December 31, 2004, was
$100.8 million, compared to $85.8 million for the twelve months ended
December 31, 2003. Revenue from clinical software and information
services for the twelve months ended December 31, 2004, was $56.0
million, increasing 41% over the comparable period last year.

Net income for the year ended December 31, 2004, of $3.1 million
or $0.07 per diluted share, compares to a net loss of $5.0 million or
$0.13 loss per share, for the year ended December 31, 2003.

Allscripts will conduct a conference call on Thursday, February
17, 2005, at 4:30 PM eastern time. The conference call can be accessed
by dialing 1-800-374-0526, or via the Internet at www.allscripts.com.
A recording of the conference call will be available for review
through March 3, 2005, at www.allscripts.com or by calling
1-800-642-1687, ID # 3686443.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions (Allscripts) is the leading
provider of clinical software, connectivity and information solutions
that physicians use to improve healthcare. The Company’s business
groups provide unique solutions that inform, connect, and transform
healthcare. The Clinical Solutions Group’s award-winning clinical
software applications include electronic health record (EHR),
e-prescribing and document imaging solutions. Additionally, Allscripts
provides healthcare product education and connectivity solutions for
physicians and patients through its Physicians Interactive(TM) Group
and medication fulfillment services through its Medication Services
Group. Visit Allscripts on the Web at www.allscripts.com.

This announcement may contain forward-looking statements about
Allscripts Healthcare Solutions that involve risks and uncertainties.
These statements are developed by combining currently available
information with Allscripts beliefs and assumptions. Forward-looking
statements do not guarantee future performance. Because Allscripts
cannot predict all of the risks and uncertainties that may affect it,
or control the ones it does predict, Allscripts’ actual results may be
materially different from the results expressed in its forward-looking
statements. For a more complete discussion of the risks, uncertainties
and assumptions that may affect Allscripts, see the Company’s 2003
Annual Report on Form 10-K, available through the Web site maintained
by the Securities and Exchange Commission at www.sec.gov.

                Allscripts Healthcare Solutions, Inc.
                Condensed Consolidated Balance Sheets
                        (amounts in thousands)
                              (Unaudited)

                                            December 31,  December 31,
Assets                                          2004          2003
------                                      ------------  ------------

 Current assets
     Cash and cash equivalents                  $16,972       $13,336
     Marketable securities                       22,796         3,435
     Accounts receivable, net                    21,382        18,219
     Other receivables                              627           237
     Inventories                                  2,372         3,249
     Prepaid expenses and other current
      assets                                      3,571         3,863
                                            ------------  ------------
          Total current assets                   67,720        42,339

 Long-term marketable securities                 88,471        34,538
 Software development costs, net                  6,270         4,040
 Fixed assets, net                                2,366         2,237
 Intangible assets, net                          24,546        26,359
 Other assets                                     4,804           879
                                            ------------  ------------
          Total assets                         $194,177      $110,392
                                            ============  ============


Liabilities and Stockholders' Equity
------------------------------------

 Current liabilities
     Accounts payable                            $5,981        $6,082
     Accrued expenses                            12,218         7,906
     Deferred revenue                            14,607        10,959
                                            ------------  ------------
          Total current liabilities              32,806        24,947

 Long-term debt                                  82,500             -
 Other liabilities                                  178         2,055
                                            ------------  ------------
          Total liabilities                     115,484        27,002


 Stockholders' equity                            78,693        83,390
                                            ------------  ------------

          Total liabilities and
           stockholders' equity                $194,177      $110,392
                                            ============  ============


Stockholders' equity includes ($11,250) of treasury shares as of
December 31, 2004 and $0 as of December 31, 2003.




                 Allscripts Healthcare Solutions, Inc.
            Condensed Consolidated Statements of Operations
           (amounts in thousands, except per-share amounts)
                              (Unaudited)


                               Three Months Ended   For the Year Ended
                                  December 31,         December 31,
                                 2004      2003       2004      2003
                              --------- ---------  --------- ---------

Revenue:
   Prepackaged medications      $9,342   $11,894    $44,733   $46,172
   Software and related
    services                    14,306     8,318     44,121    28,366
   Information services          2,665     3,441     11,916    11,303
                              --------- ---------  --------- ---------
         Total revenue          26,313    23,653    100,770    85,841

Cost of revenue:
   Prepackaged medications       7,317     9,460     35,744    36,303
   Software and related
    services                     5,154     3,264     15,858    14,050
   Information services          1,506     1,617      6,520     4,816
                              --------- ---------  --------- ---------
         Total cost of revenue  13,977    14,341     58,122    55,169
                              --------- ---------  --------- ---------

Gross profit                    12,336     9,312     42,648    30,672

Operating expenses:
   Selling, general and
    administrative expenses     10,337     9,084     37,653    36,058
   Amortization of intangibles     441       388      1,752       951
                              --------- ---------  --------- ---------
         Income (loss) from
          operations             1,558      (160)     3,243    (6,337)

Interest expense                  (884)        -     (1,717)        -
Interest income                    802       241      1,675     1,384
Other income (expense), net        (73)       35        (93)      (26)
                              --------- ---------  --------- ---------
Income (loss) before income
 taxes                           1,403       116      3,108    (4,979)

Income taxes                         -         -          -         -
                              --------- ---------  --------- ---------
Net income (loss)               $1,403      $116     $3,108   ($4,979)
                              ========= =========  ========= =========

Net income (loss) per share
 - basic                         $0.04     $0.00      $0.08    ($0.13)
                              ========= =========  ========= =========

Net income (loss) per share
 - diluted                       $0.03     $0.00      $0.07    ($0.13)
                              ========= =========  ========= =========

Weighted average shares of
 common stock outstanding
 used in computing basic net
 income (loss) per share        38,484    38,956     38,979    38,621
                              ========= =========  ========= =========

Weighted average shares of
 common stock outstanding
 used in computing diluted
 net income (loss) per share    41,439    40,700     41,592    38,621
                              ========= =========  ========= =========

    CONTACT: Allscripts Healthcare Solutions
             Dan Michelson, 312-506-1217
             dan.michelson@allscripts.com
             or
             Bill Davis, 312-506-1211
             bill.davis@allscripts.com

    SOURCE: Allscripts Healthcare Solutions
Scroll To Top